Experimental Oncology

This Division performs laboratory-based research concerned with the basic mechanisms of cancer and the clinical applications of basic cancer research.

Twelve of our principal investigators, along with six associated members, work within the Cross Cancer Institute, and an additional four, along with three associated members are located in the Katz building on the main campus of the University of Alberta.

Academic Staff supervise graduate students and medical residents, and teach in the undergraduate M.D. program, in graduate level courses in Oncology, and in graduate and undergraduate courses in related disciplines (Immunology, Biochemistry, Physics, Experimental Hematology). There are currently 29 graduate students and 12 post-doctoral fellows in Experimental Oncology.

Graduate Program             Research Facilities 

Our principal investigators perform basic scientific research and translational (bench-to-bedside) research in molecular oncology, cellular oncology, radiobiology, chemotherapy and imaging. Their work involves a variety of academic disciplines, including cellular and molecular biology, biochemistry, developmental biology, immunology, and pharmacology. Research interests include:

  • Molecular analysis of breast cancer, brain tumours, melanoma, pediatric cancers and blood cancers
  • Mechanisms underlying the repair of DNA damage caused by ionizing radiation and chemotherapeutic drugs
  • Cell adhesion, cell migration and metastatic spread
  • Epigenetics of cancer
  • Tumour suppressor genes
  • Tumour targeting viruses as cancer therapeutic agents
  • Computational biology approaches to drug discovery
  • Cell cycle regulation
  • Membrane transporters and their role in drug transport and resistance

 

Principal Investigators


Dr. Vickie Baracos

vbaracos@ualberta.ca

 

Muscle atrophy in cancer associated cachexia

Dr. Kristi Baker

kbaker2@ualberta.ca

 

Anti-tumor immunity; genetic instability; colorectal cancer

Website

Dr. Gordon Chan

gkc@ualberta.ca

 

Mitotic cell cycle checkpoint and cancer

Website

Dr. YangXin Fu

yangxin@ualberta.ca

 

Signaling pathways and gene regulation in ovarian cancer and therapeutics

Dr. Armin Gamper

gamper@ualberta.ca

DNA damage response: radiation biology

Website

Dr. Spencer Gibson

sgibson2@ualberta.ca 

 

Understanding the cell survival and cell death signaling in the lymphatic system and leukemias

 

Dr. Roseline Godbout

rgodbout@ualberta.ca

 

Cancer as a developmental disease; retinoblastoma; brain tumors

Website

Dr. Michael Hendzel

mhendzel@ualberta.ca

 

Nuclear components; DNA damage response; chromatin-based epigenetic mechanisms

Website

Dr. Mary Hitt

mary.hitt@ualberta.ca

 

Oncolytic viruses; adenovirus replication; gene regulation; RNA interference; gene therapy

 

Dr. Ismail Ismail

iismail@ualberta.ca

 

Targeting the DNA damage response in B cell malignancies

Dr. John Lewis

jdlewis@ualberta.ca

 

Translational prostate cancer research; nanoparticles, novel therapeutics, in vivo imaging

Website

Dr. Lynne Postovit   

(Adjunct Professor)

postovit@ualberta.ca

 

Environmental control of normal and cancer stem cell plasticity

Dr. Wilson Roa

wroa@ualberta.ca

 

Nono-carrier platforms for therapeutic applications; image guided radiotherapy

Dr. Michael Sawyer

msawyer@ualberta.ca

 

Cell biology, cell signaling and cancer, drug transporters

Dr. Ralf Schirrmacher

schirrma@ualberta.ca

 

Radiopharmaceutical Chemistry, development of PET imaging agents for neuro- and cancer imaging, medicinal chemistry and drug development

Website

 

Dr. Jack Tuszynski   

(Adjunct Professor)

jackt@ualberta.ca

Computational biophysics; rational drug design; pharmacokinetics

Dr. Alan Underhill

underhil@ualberta.ca

 

Transcription factors in melanoma; gene regulation & epigenetics

Dr. Michael Weinfeld

mweinfel@ualberta.ca

 

Detection and repair of DNA damage

Dr. Frank Wuest

wuest@ualberta.ca

 

Probe development for molecular imaging of cancer

Website